Literature DB >> 22262368

Mechanism of interstrand migration of organoruthenium anticancer complexes within a DNA duplex.

Kui Wu1, Qun Luo, Wenbing Hu, Xianchan Li, Fuyi Wang, Shaoxiang Xiong, Peter J Sadler.   

Abstract

Organometallic ruthenium(ii) anticancer complexes [(η(6)-arene)Ru(en)Cl][PF(6)] (e.g. arene = biphenyl (bip, 1), indane (ind, 2); en = ethylenediamine) bind to N7 of guanine (G) in DNA selectively. The fragment {(η(6)-bip)Ru(en)}(2+) (1') bound to N7 of one guanine residue at a 14-mer duplex DNA migrates readily to other guanine residues in both the same strand and the complementary strand when the strands are hybridized at elevated temperature. In this work, by applying HPLC coupled to mass spectrometry, the mechanism of such intra- and interstrand migration was investigated using a 15-mer duplex, in which one strand 5'-CTCTCTTG(8)TCTTCTC-3' (I) contained a single guanine (G(8)). The results show that the interstrand migration of complexes 1 and 2 within the duplex involves an SN1 pathway, firstly solvent-assisted dissociation of the initially G(8)-bound adducts I-G(8)-1' and I-G(8)-2' (2' = {(η(6)-ind)Ru(en)}(2+)) as the rate-controlling step, and secondly the coordination of the dissociated 1' and 2' to guanine bases (G(21) for 1', either G(21) or G(18) for 2') on strand II. The high temperature used to anneal the single strands was found to increase the migration rate. The formation of the duplex acts as a key driving force to promote the dissociation of G(8)-bound 1' and 2' due to the competition of cytosine in II with the en-NH(2) groups in 1' and 2' for H-bonding with C6O of guanine. Complex 2 (t(1/2) = 18 h) containing a mono-ringed arene ligand dissociates more readily from the initially binding site G(8) than complex 1 (t(1/2) = 23 h). The extended biphenyl arene ligand which is intercalated into DNA stabilizes the adduct I-G(8)-1'. These results provide new insight into this unusual metal migration, and are of significance for the design and development of more active organometallic ruthenium anticancer complexes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22262368     DOI: 10.1039/c2mt00162d

Source DB:  PubMed          Journal:  Metallomics        ISSN: 1756-5901            Impact factor:   4.526


  4 in total

1.  Competitive binding sites of a ruthenium arene anticancer complex on oligonucleotides studied by mass spectrometry: ladder-sequencing versus top-down.

Authors:  Kui Wu; Wenbing Hu; Qun Luo; Xianchan Li; Shaoxiang Xiong; Peter J Sadler; Fuyi Wang
Journal:  J Am Soc Mass Spectrom       Date:  2013-02-13       Impact factor: 3.109

2.  A comparative DFT study on aquation and nucleobase binding of ruthenium (II) and osmium (II) arene complexes.

Authors:  Hanlu Wang; Xingye Zeng; Rujin Zhou; Cunyuan Zhao
Journal:  J Mol Model       Date:  2013-09-15       Impact factor: 1.810

3.  Radiosensitisation of human colorectal cancer cells by ruthenium(II) arene anticancer complexes.

Authors:  R Carter; A Westhorpe; M J Romero; A Habtemariam; C R Gallevo; Y Bark; N Menezes; P J Sadler; R A Sharma
Journal:  Sci Rep       Date:  2016-02-12       Impact factor: 4.379

4.  Binding of Organometallic Ruthenium Anticancer Complexes to DNA: Thermodynamic Base and Sequence Selectivity.

Authors:  Suyan Liu; Aihua Liang; Kui Wu; Wenjuan Zeng; Qun Luo; Fuyi Wang
Journal:  Int J Mol Sci       Date:  2018-07-23       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.